back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-04 10:31 Tx date 2026-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,412 vol |
189,913 | |
| Filed 2026-04-17 16:06 Tx date 2016-11-28 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
463,250 | |
| Filed 2026-04-17 16:05 Tx date 2026-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,175 vol |
105,337 | |
| Filed 2026-04-17 16:04 Tx date 2025-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+10,861 vol |
99,162 | |
| Filed 2026-04-17 16:03 Tx date 2024-01-02 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+19,196 vol |
88,301 | |
| Filed 2026-04-17 16:01 Tx date 2023-01-03 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+35,130 vol |
69,105 | |
| Filed 2025-06-03 16:10 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,162 vol |
144,501 | |
| Filed 2024-06-18 16:54 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,472 vol |
112,339 | |
| Filed 2023-06-26 12:47 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-15,000 vol |
97,748 | |
| Filed 2023-06-26 12:46 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$254,150
+65,000 vol $3.91 each |
112,748 | |
| Filed 2023-06-05 16:34 Tx date 2023-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+16,968 vol |
83,867 | |
| Filed 2022-02-10 16:36 Tx date 2022-01-03 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+15,026 vol |
112,753 | |
| Filed 2022-02-10 16:35 Tx date 2022-02-10 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
99 - Correction of information
|
-585,750 vol |
66,899 | |
| Filed 2022-02-10 16:34 Tx date 2021-10-06 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,250 vol |
652,649 | |
| Filed 2022-02-10 16:33 Tx date 2016-04-13 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-1,250 vol |
358,250 | |
| Filed 2022-02-10 16:32 Tx date 2016-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-5,500 vol |
384,500 | |
| Filed 2022-02-10 16:29 Tx date 2022-02-10 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
99 - Correction of information
|
-78,778 vol |
33,975 | |
| Filed 2022-02-10 16:27 Tx date 2022-01-03 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+15,026 vol |
||
| Filed 2022-02-09 18:41 Tx date 2021-01-01 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$57,766
+7,019 vol $8.23 each |
97,727 | |
| Filed 2022-02-09 18:38 Tx date 2020-03-29 |
$DMAC
DiaMedica Therapeutics Inc. |
GIUFFRE, MICHAEL
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-204,082 vol |
0 |